A detailed history of Axxcess Wealth Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Axxcess Wealth Management, LLC holds 1,283 shares of CRL stock, worth $242,910. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,283
Previous 1,324 3.1%
Holding current value
$242,910
Previous $273,000 7.69%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$187.96 - $245.29 $7,706 - $10,056
-41 Reduced 3.1%
1,283 $252,000
Q2 2024

Aug 09, 2024

SELL
$206.39 - $268.73 $158,920 - $206,922
-770 Reduced 36.77%
1,324 $273,000
Q1 2024

May 14, 2024

BUY
$203.52 - $273.43 $150,808 - $202,611
741 Added 54.77%
2,094 $567,000
Q4 2023

Feb 06, 2024

SELL
$164.52 - $238.84 $1,645 - $2,388
-10 Reduced 0.73%
1,353 $319,000
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $27,416 - $30,683
141 Added 11.54%
1,363 $267,000
Q2 2023

Aug 08, 2023

SELL
$183.71 - $210.25 $11,206 - $12,825
-61 Reduced 4.75%
1,222 $256,000
Q1 2023

May 03, 2023

SELL
$191.89 - $259.92 $191 - $259
-1 Reduced 0.08%
1,283 $258,000
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $164,586 - $208,808
-835 Reduced 39.41%
1,284 $279,000
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $22,622 - $31,066
124 Added 6.22%
2,119 $417,000
Q2 2022

Aug 11, 2022

SELL
$204.13 - $302.4 $95,328 - $141,220
-467 Reduced 18.97%
1,995 $426,000
Q1 2022

Aug 11, 2022

SELL
$255.51 - $362.11 $153,817 - $217,990
-602 Reduced 19.65%
2,462 $699,000
Q4 2021

Aug 11, 2022

BUY
$351.38 - $448.68 $1.08 Million - $1.37 Million
3,064 New
3,064 $1.15 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.63B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Axxcess Wealth Management, LLC Portfolio

Follow Axxcess Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axxcess Wealth Management, LLC with notifications on news.